Ann M. Knolhoff, PhD FDA/CFSAN/ORS [email protected]

26
Introduction to Metabolic Profiling Ann M. Knolhoff, PhD FDA/CFSAN/ORS [email protected]

Transcript of Ann M. Knolhoff, PhD FDA/CFSAN/ORS [email protected]

Page 1: Ann M. Knolhoff, PhD FDA/CFSAN/ORS ann.knolhoff@fda.hhs

Introduction to Metabolic Profiling

Ann M. Knolhoff, PhDFDA/CFSAN/[email protected]

Page 2: Ann M. Knolhoff, PhD FDA/CFSAN/ORS ann.knolhoff@fda.hhs

Metabolomics

Goal: complete small molecule characterization

Complementary to other chemical characterizations

Often used to link chemical content to phenotype

Genomics (genes)

Transcriptomics (mRNA)

Proteomics (proteins)

Metabolomics (metabolites)

Page 3: Ann M. Knolhoff, PhD FDA/CFSAN/ORS ann.knolhoff@fda.hhs

The Metabolome Includes Diverse Analytes

Amino acids Lipids Steroids Small peptides Carbohydrates Exogenous drugs/metabolites Many others…

Page 4: Ann M. Knolhoff, PhD FDA/CFSAN/ORS ann.knolhoff@fda.hhs

Metabolite Profiling vs. Metabolomics

Metabolite profiling– Targeted screening– Can be quantitative– Will miss compounds that

are not on list Metabolomics

– Non-targeted screening– All encompassing

Page 5: Ann M. Knolhoff, PhD FDA/CFSAN/ORS ann.knolhoff@fda.hhs

Metabolomic Applications

Disease, injury, and disorders Model organisms Gene modifications Exposure effects

– Drug metabolism– Toxins

0

200

400

600

800

1000

1200

2001

2003

2005

2007

2009

2011

2013

2015

2017

Num

ber o

f Pub

licat

ions

Year

Publications with “Metabolomics” in the Title

Many of these studies are comparative

Page 6: Ann M. Knolhoff, PhD FDA/CFSAN/ORS ann.knolhoff@fda.hhs

Metabolomics in Plant Biology

Bigger genomes, bigger metabolome– >200,000 metabolites predicted1

Applications2

– Plant growth & development– Crop quality– Stress responses

o Abiotico Biotic

– Medicinal plantso Natural products

Page 7: Ann M. Knolhoff, PhD FDA/CFSAN/ORS ann.knolhoff@fda.hhs

Most Commonly Used Analytical TechniquesNuclear Magnetic Resonance (NMR) SpectroscopyChemical shifts based on structure Structure elucidation Non-destructive Sample preparation is minimal Fast acquisition Can be quantitative Reproducible

Mass Spectrometry (MS)

Mass-to-charge (m/z) ratios of ions 1000s of compounds can be

detected in a single sample Better limits of detection Large dynamic range

Complementary

Page 8: Ann M. Knolhoff, PhD FDA/CFSAN/ORS ann.knolhoff@fda.hhs

Chemical Separation Prior to Mass Spectrometry

Gas chromatography (GC)– Interaction with stationary phase– Volatile compounds– Reference spectra

Liquid chromatography (LC)– Interaction with stationary phase– Hydrophilic and hydrophobic

compounds Capillary electrophoresis (CE)

– Size and charge– Polar and ionic compounds

Page 9: Ann M. Knolhoff, PhD FDA/CFSAN/ORS ann.knolhoff@fda.hhs

0.0E+00

2.0E+06

4.0E+06

6.0E+06

8.0E+06

1.0E+07

1.2E+07

1.4E+07

Num

ber o

f Com

poun

dsMass Range Searched (Da)

Reference 4

High Resolution Mass Spectrometry (HR-MS)

Accurate mass Molecular formula generation

– 80-90% probability of correct formula with <3 ppm error & <5% absolute isotope ratio3

Resolution of compounds with similar m/z values

Inte

nsity

m/z

366.1118

+ 3 ppm366.1107-366.1129

0.E+00

1.E+05

2.E+05

3.E+05

300-

301

301-

302

302-

303

303-

304

304-

305

Page 10: Ann M. Knolhoff, PhD FDA/CFSAN/ORS ann.knolhoff@fda.hhs

Resolving Power

Page 11: Ann M. Knolhoff, PhD FDA/CFSAN/ORS ann.knolhoff@fda.hhs

Mass Spectrometry Imaging

Reference 5

Page 12: Ann M. Knolhoff, PhD FDA/CFSAN/ORS ann.knolhoff@fda.hhs

Considerations with Sample Preparation for LC/MS

Sampling and sample sizes Quenching metabolism Replicates Compounds of interest

– Matrix effects Sample and analyte stability Extraction blank Matrix spikes

Page 13: Ann M. Knolhoff, PhD FDA/CFSAN/ORS ann.knolhoff@fda.hhs

LC/MS Data Analysis for Metabolite Profiling

Specified analytes Monitor m/z and

retention time Can be done with

a fairly large list of compounds

Retention Time

Inte

nsity

Extracted Ion Chromatograme.g., m/z 366.1107-366.1129

Page 14: Ann M. Knolhoff, PhD FDA/CFSAN/ORS ann.knolhoff@fda.hhs

LC/MS Data Analysis Challenges for Metabolomics

Hundreds to thousands of m/z values detected in one analysis

Many unknown analytes Background vs sample Different ion types

– Adducts and fragments– Multiply charged ions

Reproducibility (target vs suspect screening)

Page 15: Ann M. Knolhoff, PhD FDA/CFSAN/ORS ann.knolhoff@fda.hhs

Non-Targeted Data Analysis Workflow

Componentization

Statistical Analysis, ID Sample Outliers and

Differentiating Compounds

Formula GenerationC16H18N2O4S

Database Searching

Interpretation of Ions

m/z?Adducts?

MS/MS Approaches

∆m/z

Putative ID, Confirm with Analytical Standard

Identification Strategies

QCs should be used to

confirm accuracy of

methods

Modified from Reference 5

Page 16: Ann M. Knolhoff, PhD FDA/CFSAN/ORS ann.knolhoff@fda.hhs

Sample complexity– Ion suppression– Matrix effects

Dynamic range Chromatography Mass resolution Data analysis software

Factors That Can Influence Data Output and Quality

Componentization Interpretation of Ions

m/z?Adducts?

Page 17: Ann M. Knolhoff, PhD FDA/CFSAN/ORS ann.knolhoff@fda.hhs

Reducing Number of Features is Critical

Feature = one detected compound with all associated ions

100s-1000s of features can be detected in a single sample

May not care about identifying everything

Multiple molecular formulae can be generated for a single feature

x 10

0

x 10

0

x 10

0

x 30

05

101520253035404550

Num

ber o

f Com

poun

ds

Molecular Formula

SciFinder ChemSpider PubChem Metlin

Reference 4

C3H6N6 C16H18N2O4S C19H28O2

Page 18: Ann M. Knolhoff, PhD FDA/CFSAN/ORS ann.knolhoff@fda.hhs

MS/MS Identification

Tandem mass spectrometry (MS/MS) can aid in identifying compounds Used in both targeted and non-targeted methods MS/MS libraries are available

m/z

Inte

nsity A

m/zIn

tens

ity

ABC

D

MS MS2

m/z

Inte

nsity

BEF

m/zInte

nsity

HDMS3

MS3

Page 19: Ann M. Knolhoff, PhD FDA/CFSAN/ORS ann.knolhoff@fda.hhs

Comparative Analyses Aid in Highlighting Relevant Features

Comparison# of features after

background subtract

# of features after processing

w/ QC*

# of features after processing

w/o QC*Spiked Rolled Oats vs. Same Brand 3024 13 8

Spiked Rolled Oats vs. All Brands 4703 13 1

* Median area >1e5, Adjusted p-value <0.05, Ratio >2

Page 20: Ann M. Knolhoff, PhD FDA/CFSAN/ORS ann.knolhoff@fda.hhs

-40

-20

0

20

40

60

80

-60 -40 -20 0 20 40 60 80

Spiked Lot, Brand 1Unspiked Lot, Brand 1Brand 1Brand 2Brand 3Brand 4

Irish Oats

Principal Component Analysis (PCA)

Rolled Oats

PC1

PC2

Page 21: Ann M. Knolhoff, PhD FDA/CFSAN/ORS ann.knolhoff@fda.hhs

PCA, Types of Oats

-50-40-30-20-10

010203040

-60 -40 -20 0 20 40 60 80 100Oat BranOat FlourOld FashionedRolledSteel Cut

Steel Cut

Oat Bran

Oat Flour

Old Fashioned

Rolled

Brand 4Brand 3

PC1

PC2

Page 22: Ann M. Knolhoff, PhD FDA/CFSAN/ORS ann.knolhoff@fda.hhs

Non-Targeted Data Analysis Workflow

Componentization

Statistical Analysis, ID Sample Outliers and

Differentiating Compounds

Formula GenerationC16H18N2O4S

Database Searching

Interpretation of Ions

m/z?Adducts?

MS/MS Approaches

∆m/z

Putative ID, Confirm with Analytical Standard

Identification Strategies

QCs should be used to

confirm accuracy of

methods

Modified from Reference 5

Page 23: Ann M. Knolhoff, PhD FDA/CFSAN/ORS ann.knolhoff@fda.hhs

Major Points

Challenges in Metabolomics– Data mining– Throughput

Advantages of Metabolomics– Information-rich data sets– Determine molecular differences between control and altered states– Identify molecular targets that can be screened

Page 24: Ann M. Knolhoff, PhD FDA/CFSAN/ORS ann.knolhoff@fda.hhs

Metabolomics of GE Foods, Selected Publications

“Hierarchical metabolomics demonstrates substantial compositional similarity between genetically modified and conventional potato crops”

“Metabolic profiling based on LC/MS to evaluate unintended effects of transgenic rice with cry1Ac and sck genes”

“Metabolic changes in transgenic maize mature seeds over-expressing the Aspergillus niger phyA2”

“Covering chemical diversity of genetically-modified tomatoes using metabolomics for objective substantial equivalence assessment”

“Assessing metabolomic and chemical diversity of a soybean lineage representing 35 years of breeding”

“Seed metabolomic study reveals significant metabolite variations and correlations among different soybean cultivars”

“An integrated multi-omics analysis of the NK603 Roundup-tolerant GM maize reveals metabolism disturbances caused by the transformation process”

Page 25: Ann M. Knolhoff, PhD FDA/CFSAN/ORS ann.knolhoff@fda.hhs

References

1. R.A. Dixon, D. Strack, Phytochemistry meets genome analysis, and beyond, Phytochemistry, 62 (2003) 815-816.

2. J. Hong, L. Yang, D. Zhang, J. Shi, Plant Metabolomics: An Indispensable System Biology Tool for Plant Science, International Journal of Molecular Sciences, 17 (2016) 767.

3. T. Kind, O. Fiehn, Seven Golden Rules for heuristic filtering of molecular formulas obtained by accurate mass spectrometry, BMC Bioinformatics, 8 (2007) 105.

4. A.M. Knolhoff, T.R. Croley, Non-targeted screening approaches for contaminants and adulterants in food using liquid chromatography hyphenated to high resolution mass spectrometry, Journal of Chromatography A, 1428 (2016) 86-96.

5. A.R. Korte, M.D. Yandeau-Nelson, B.J. Nikolau, Y.J. Lee, Subcellular-level resolution MALDI-MS imaging of maize leaf metabolites by MALDI-linear ion trap-Orbitrap mass spectrometer, Analytical and Bioanalytical Chemistry, 407 (2015) 2301-2309.

Page 26: Ann M. Knolhoff, PhD FDA/CFSAN/ORS ann.knolhoff@fda.hhs

Acknowledgments

Tim Croley Christine Fisher Clark Ridge Steve Swatkoski